| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |